We found 6 specific proteins (NTRK2, MAPKAPK2, JUND, CRK, PPP3R1, and NFATC2) of the MAPK pathway, which participate in the progression of HCC from stage I to stage II. The gene discussed is MAPKAPK2; the disease is hepatocellular carcinoma.